ARCHIVES

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

NCI Trials Listed

June 25, 2010

Gerstner Resigns From NA, MSK Board After Taking RJR Job

March 24, 1989

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014